LCD Display Garners FDA Clearance

Julie Ritzer Ross | | Radiology Business | Business Intelligence
imageAmpronix Incorporated last week announced that its Modalixx G202MP autosync modality LCD display has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The monitor is among several products marketed by the company as the first universal solutions for medical-modality CRT monitor replacement with premium medical-grade LCD displays. It is said to offer a comprehensive set of inputs that enables auto-synchronization interfacing with the broadest range of connectivity requirements for medical applications. The Modalixx G202MP displays images on a 20.1-inch LCD screen, at a contrast ratio of a brightness level of 1000 cd/m2. Image enhancement features automatically up-scale any legacy analog-captured image input, displaying it as a true 2MP image. The display can be used in MRI, CT, endoscopy, radiography, DR, CR, cath lab, RF, Mobile C-Arm, mobile digital X-ray, and PET. Says Nelson Fathollahi, President and CEO of Ampronix, “What makes the Modalixx unique is that it is capable of auto-synchronizing with many different modality signals while enhancing the image quality at the same time. This gives doctors a clearer image in critical applications, like the cath lab.”

Julie Ritzer Ross,

Contributor

Related Content

Orano Med breaks ground on $265M thorium production site
Image-interpretation market scoreboard: Radiologists 72%, others 28%
Lantheus lands rights to budding radiopharmaceuticals for initial outlay of $35M
17 short-term strategies to address the national radiologist shortage
‘SR’ onboards another independent practice, its 1st in the Natural State
Analysis: Allied radiology professionals generate millions of dollars per year in indirect revenues alone

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.